Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor

US Patent 11459390 · Granted Oct 4, 2022

Estimated economic value: $49,982,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Organic light-emitting device and organometallic compound2025
Hydrogel-based biomedical devices for therapeutic hydrogen treatment of skin and2025
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
CLDN18.2-targeting antibody, bispecific antibody and use thereof2025
Matte ceramic tile and preparation method thereof2025
Switch costimulatory receptors2025
Methods and compositions for assessing and treating intraocular diseases and dis2025
Chimeric antigen receptors and uses thereof2025
Compositions and methods for generating a persisting population of T cells usefu2025
Automatic data purge verification2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025